Press Releases

Media Contact:
Amanda Ulrey
aulrey@iivs.org
301-947-6523

IIVS Appointed to China’s Alternatives Working Group for Cosmetics

October 9, 2018

Gaithersburg, MD – October 9, 2018 – U.S. based Institute for In Vitro Sciences (IIVS) has been invited by China’s National Institute for Food and Drug Control (NIFDC) to join their working group on alternatives for cosmetics.  The newly established group was announced by the NIFDC during their 2nd International ...

IIVS Collaborates with BASF and Givaudan to Validate a Non-animal Test for Regulatory Submissions

August 28, 2018

GAITHERSBURG, MD –August 28– The Institute for In Vitro Sciences (IIVS), with an established track record in the validation of alternatives to animal testing, is teaming up with BASF and Givaudan to validate an improved skin sensitization reactivity method to address the needs of ...

IIVS Names Frank Gerberick as Chief Scientific Advisor

March 1, 2018

GAITHERSBURG, MD – March 1, 2018 – The Institute for In Vitro Sciences, Inc. (IIVS) announced that it has appointed Frank Gerberick, PhD as its Chief Scientific Advisor. With his expertise and knowledge of technological advances and industry trends, Dr. Gerberick will advise the organization’s governing body on scientific matters and make recommendations on future directions...

IIVS and BASF Collaborate to Distribute Test Method to Replace Animal Testing in China

January 9, 2018

GAITHERSBURG, MD – January 9, 2018 – The Institute for In Vitro Sciences, Inc. (IIVS) today announced a collaboration with BASF to import a non-animal, cell based, safety test into China. The LuSens test, developed by BASF, is an in vitro...

IIVS Announces the Opening of a Non-animal Testing Laboratory in China

November 14, 2017

GAITHERSBURG, MD – Nov. 14, 2017 – The Zhejiang Institute for Food and Drug Control (ZJIFDC), responsible for  regulatory review of food, drugs, and cosmetics produced in Zhejiang province, has opened a non-animal testing laboratory after successful scientific collaboration with IIVS.  Based near Shanghai, the ZJIFDC made the decision to open the new lab back in 2013 to keep...

IIVS and Colgate-Palmolive Team Up to Provide Training on Non-Animal Methods in Brazil

October 10, 2017

GAITHERSBURG, MD – Oct. 10, 2017 – IIVS, supported by a grant from Colgate-Palmolive, held a training course this month in Goiania, Brazil focused on two in vitro methods with international regulatory acceptance status. The course, Alternative Methods for Evaluation of Toxicity, was attended by over 30 participants from industry and government who ...

Chinese FDA and IIVS Re-affirm Their Collaboration for Non-animal Tests

September 7, 2017

GAITHERSBURG, MD – Sept. 7, 2017 – Bo Li, General Director of the CFDA’s National Institute for Food and Drug Control (NIFDC) and Erin Hill, President of US based non-profit, Institute for In Vitro Sciences, Inc. (IIVS), signed a Memorandum of Understanding (MOU) to bring non-animal test methods to China for the regulation of cosmetics and ingredients. The move re-affirms ...

Collaborative Effort Aims to Replace Rabbit Test for Personal Lubricant Products

August 21, 2017

Study in Response to Consumer Demands for Humane Testing

Washington, D.C. — August 21, 2017 — A first-of-its kind collaborative project is underway to find a non-animal test method to replace the rabbit vaginal irritation test for personal lubricants. The U.S. Food and Drug Administration (FDA) gave the project a green light as part...

IIVS Recipient of Device that Mimics Human Exposure to Aerosols

July 10, 2017

PETA International Science Consortium Donates VITROCELL® In Vitro Inhalation Exposure System

GAITHERSBURG, MD – July 10, 2017 – The Institute for In Vitro Sciences (IIVS), a leader in non-animal test methods, is the recipient of a VITROCELL® inhalation exposure system thanks to a generous...

New In Vitro Respiratory Laboratory, Marking 20 Years of Innovation in Non-Animal Testing

June 13, 2017

GAITHERSBURG, MD – June 13, 2017 – The Institute for In Vitro Sciences (IIVS), a leader in non-animal test methods, marked its 20th year with the opening of a new state-of-the-art in vitro respiratory exposure laboratory. The 1,000 square foot facility expands IIVS’ non-animal testing services to include rapid evaluation of potential respiratory hazards associated with novel ...